fda warning glp-1 compounding september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA issued 25 warning letters

This can manifest as mild puffiness in the hands, feet, or face, particularly in the first 2 to 4 weeks

Both support once-weekly dosing

Faheem H, Alawadhi R, Basha E, Ismail R, Ibrahim HA, Elshamy AM, Motawea SM, Seleem MA, Elkordy A, Homouda AA et al

Obesity happens when your body stores too much fat, to the point where it can affect your health

Cellular Delivery: This method is designed to support absorption at the cellular level, ensuring the antioxidant actually gets to where it is needed most

The elevated glutathione levels in the cells result in insulin binding to carrier proteins, which helps glucose uptake and utilization [8]